Producer

Thermo Fisher Scientific

TMOHQ US · Massachusettswebsite ↗

Thermo Fisher Scientific (Waltham MA; NYSE: TMO; ~$43B revenue 2024) is the world's largest manufacturer of cell culture media through its Gibco brand — the dominant label in CHO (Chinese Hamster Ovary) cell culture media for biopharmaceutical manufacturing. Gibco CHO-S Serum-Free Medium, GlutaMAX supplement, CD CHO medium, and EX-CELL Advanced CHO media series supply the majority of global monoclonal antibody manufacturing processes. Thermo Fisher's cell culture media is manufactured primarily at its Grand Island, NY facility (acquired from Life Technologies, itself formerly GIBCO BRL), which is the single most important cell culture media manufacturing site in North America. Thermo Fisher also operates a major media production site in Paisley, Scotland (UK) that serves European biopharmaceutical manufacturing. Gibco media formulations are validated into more FDA-approved biologics manufacturing processes than any other supplier — creating regulatory lock-in equivalent to Cytiva's position in chromatography resins. The 2014 Thermo Fisher merger with Life Technologies (which itself had acquired Invitrogen in 2008 and GIBCO BRL in 2000) consolidated what were once multiple competing cell culture brands into a single dominant supplier.

5

Inputs supplied

2

Goods downstream

4

Facilities

0

Stories

Where it shows up

Goods downstream

Essential goods that depend on something Thermo Fisher Scientific makes, pick one to see the full supply chain.

Where they make it

4 facilities

Thermo Fisher Bridgewater NJ Bioprocessing (US)

US

New Jersey · manufacturing

Thermo Fisher Scientific's primary US single-use bioreactor bag manufacturing site in Bridgewater, NJ; produces HyPerforma SU bioreactor bags using TE-Flex multilayer film. This facility also manufactures cell culture media (HyClone brand) and other bioprocessing consumables. Bridgewater was a key site in Thermo Fisher's COVID-19 response manufacturing as a Pfizer and Moderna supply chain partner. Source: https://www.thermofisher.com/us/en/home/life-science/bioproduction/single-use-bioreactors.html

Thermo Fisher Carlsbad CA Genomics Manufacturing

US

California · processing

Thermo Fisher Carlsbad site (former Invitrogen headquarters); produces TRIzol reagent, Applied Biosystems PCR reagents, MagMAX RNA purification kits; key US source of RNA extraction components for clinical and research labs

Thermo Fisher Gibco Cell Culture Media Plant (Grand Island, NY)

US

New York · manufacturing

Thermo Fisher Scientific Grand Island, NY campus — primary North American Gibco cell culture media manufacturing site. Originally the GIBCO BRL (Grand Island Biological Company) facility that gave Gibco its name, founded in Grand Island NY in 1953. The facility produces liquid and powder CHO cell culture media formulations at large scale. Grand Island is one of the world's most important single sites for biopharmaceutical consumables. Source: https://www.thermofisher.com/us/en/home/about-us/contact-us/site-information.html

Thermo Fisher Gibco Cell Culture Media Plant (Paisley, Scotland)

GB

Scotland · manufacturing

Thermo Fisher Scientific Paisley, Scotland — primary European Gibco cell culture media manufacturing site. Serves European biopharmaceutical manufacturing customers. Legacy site of Gibco European operations. Produces liquid media and powder media for CHO and other mammalian cell culture. Source: https://www.thermofisher.com/us/en/home/life-science/cell-culture.html

What else they do

Business segments

The company's full revenue map, where this supply-chain role fits within their broader business.

  • Life Sciences Solutions

    40%
  • Analytical Instruments

    25%
  • Laboratory Products & Services

    25%
  • Specialty Diagnostics

    10%

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

  • Concentration2023

    Thermo Fisher Scientific's Gibco brand traces its name to the Grand Island Biological Company, founded in Grand Island, New York in 1953 by Justin and Margaret Pletcher — a small biological supply company that began by selling biological reagents to university researchers. GIBCO was acquired by a succession of companies over decades: Dexter Corporation, Life Technologies, Invitrogen (2000), and finally Thermo Fisher Scientific via its $13.6B acquisition of Life Technologies in 2014. The cell culture media for virtually every FDA-approved monoclonal antibody manufactured in North America was originally formulated by researchers sourcing from a company started by two scientists in a small town near Niagara Falls in 1953. The 2014 Thermo Fisher/Life Technologies merger — which received regulatory clearance with minimal remedies — created a dominant position in cell culture media that FDA's biologics review process subsequently locked in by accepting Gibco-formulated media in thousands of BLA submissions. The concentration of global mAb media supply in one company (Thermo Fisher) with one primary manufacturing site (Grand Island NY) is a direct consequence of merger approvals that did not account for FDA's BLA-anchored switching cost mechanism.

    Thermo Fisher Scientific
  • Incident2020

    In March 2020, Thermo Fisher Scientific announced it would produce 5 million COVID-19 PCR tests per week by April 2020. But the bottleneck was not the test kits themselves — it was the RNA extraction reagents needed before the PCR step. Thermo Fisher's TRIzol extraction protocol, widely used in research labs pressed into diagnostic service during the crisis, was not optimized for high-throughput clinical automation, meaning labs could not simply redeploy research-grade Thermo Fisher reagents for clinical-scale testing without operational workarounds.

    Chemical & Engineering News (American Chemical Society)